Samsung Bioepis is Biotechnology in South Korea that focus on developer business. Founded in 2012. They cover business area such as developer, biopharmaceutical and biosimilar medicine, patient access, high-quality treatment option, an extensive pipeline, biosimilar candidate, high-quality and process innovation, innovative therapy, neurodegenerative disease, hemophilia, auto-immune disorder.
2012
( 12 years old in 2024 )
Developer
-
107, Cheomdan-daero
Yeonsu-gu
Incheon, 21987
South Korea
Private
developerbiopharmaceutical and biosimilar medicinepatient accesshigh-quality treatment optionan extensive pipelinebiosimilar candidatehigh-quality and process innovationinnovative therapyneurodegenerative diseasehemophiliaauto-immune disorder
* We use standard office opening hours in near Samsung Bioepis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Samsung Bioepis is Biotechnology business from South Korea that founded in 2012 (12 years old in 2024), Samsung Bioepis business is focusing on Developer.
Samsung Bioepis headquarter office and corporate office address is located in 107, Cheomdan-daero Yeonsu-gu Incheon, 21987 South Korea.
Samsung Bioepis was founded in South Korea.
In 2024, Samsung Bioepis is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Samsung Bioepis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.